CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 99 filers reported holding CALITHERA BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $61,000 | -40.2% | 150,688 | -1.5% | 0.00% | – |
| Q4 2021 | $102,000 | -69.5% | 152,977 | -0.2% | 0.00% | – |
| Q3 2021 | $334,000 | +30.0% | 153,282 | +24.9% | 0.00% | – |
| Q2 2021 | $257,000 | -84.7% | 122,716 | -82.4% | 0.00% | – |
| Q1 2021 | $1,684,000 | -54.4% | 695,757 | -7.6% | 0.00% | -100.0% |
| Q4 2020 | $3,697,000 | +39.4% | 752,927 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $2,653,000 | -37.0% | 769,033 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $4,209,000 | +43.0% | 796,945 | +20.2% | 0.00% | 0.0% |
| Q1 2020 | $2,943,000 | -9.3% | 662,991 | +16.7% | 0.00% | 0.0% |
| Q4 2019 | $3,245,000 | +96.4% | 568,217 | +6.3% | 0.00% | – |
| Q3 2019 | $1,652,000 | +6.6% | 534,347 | +34.6% | 0.00% | – |
| Q2 2019 | $1,549,000 | -37.9% | 396,875 | +7.3% | 0.00% | -100.0% |
| Q1 2019 | $2,494,000 | +77.1% | 369,953 | +5.4% | 0.00% | – |
| Q4 2018 | $1,408,000 | -25.0% | 350,966 | -1.9% | 0.00% | – |
| Q3 2018 | $1,878,000 | +15.4% | 357,721 | +9.9% | 0.00% | – |
| Q2 2018 | $1,628,000 | -23.2% | 325,603 | -3.2% | 0.00% | -100.0% |
| Q1 2018 | $2,120,000 | -24.9% | 336,457 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $2,823,000 | -46.4% | 338,122 | +1.2% | 0.00% | 0.0% |
| Q3 2017 | $5,263,000 | +5.0% | 334,183 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $5,014,000 | +1770.9% | 337,640 | +1355.1% | 0.00% | – |
| Q1 2017 | $268,000 | +370.2% | 23,204 | +32.9% | 0.00% | – |
| Q4 2016 | $57,000 | +5.6% | 17,457 | +5.8% | 0.00% | – |
| Q3 2016 | $54,000 | -11.5% | 16,498 | 0.0% | 0.00% | – |
| Q2 2016 | $61,000 | -89.6% | 16,498 | -84.0% | 0.00% | – |
| Q1 2016 | $585,000 | -26.1% | 103,048 | -0.4% | 0.00% | – |
| Q4 2015 | $792,000 | +46.9% | 103,411 | +4.2% | 0.00% | – |
| Q3 2015 | $539,000 | -7.1% | 99,274 | +22.2% | 0.00% | – |
| Q2 2015 | $580,000 | -56.4% | 81,222 | +0.2% | 0.00% | – |
| Q1 2015 | $1,331,000 | -18.1% | 81,087 | +0.8% | 0.00% | – |
| Q4 2014 | $1,626,000 | – | 80,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,290,000 | 3.82% |
| BVF INC/IL | 7,452,331 | $16,246,000 | 0.63% |
| TSP Capital Management Group, LLC | 661,600 | $1,442,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,245 | $406,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 525,667 | $1,146,000 | 0.12% |
| Parkman Healthcare Partners LLC | 100,628 | $219,000 | 0.06% |
| FEDERATED HERMES, INC. | 6,668,978 | $14,539,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 133,700 | $291,000 | 0.02% |
| Ergoteles LLC | 274,805 | $599,000 | 0.02% |
| Seelaus Asset Management LLC | 16,150 | $35,000 | 0.02% |